MAR 17, 2015 08:43 AM PDT

Mass Spec and Microscopy Image Fusion

WRITTEN BY: Judy O'Rourke
Vanderbilt University researchers have achieved the first "image fusion" of mass spectrometry and microscopy - a technical tour de force that could, among other things, dramatically improve the diagnosis and treatment of cancer.

Microscopy can yield high-resolution images of tissues, but "it really doesn't give you molecular information," says Richard Caprioli, PhD, senior author of the paper recently published in the journal Nature Methods.
Image of a section of the brain shows the fusion of microscopy (pink area) and mass spectrometry (pixelated colors at bottom) to produce a detailed
Mass spectrometry provides a very precise accounting of the proteins, lipids, and other molecules in a given tissue, but in a spatially coarse or pixelated manner. Combining the best features of both imaging modalities allows scientists to see the molecular make-up of tissues in high resolution.

"That to me is just phenomenal," says Caprioli, the Stanford Moore Professor of Biochemistry and director of the Mass Spectrometry Research Center.

Caprioli says the technique could redefine the surgical "margin," the line between cancer cells and normal cells where the scalpel goes to remove the tumor.

Currently that line is determined by histology - the appearance of cells examined under the microscope. But many cancers recur after surgery. That could be because what appear to be normal cells, when analyzed for their protein content using mass spectrometry, are actually cancer cells in the making.

"The application of image fusion approaches to the analysis of tissue sections by microscopy and mass spectrometry is a significant innovation that should change the way that these techniques are used together," says Douglas Sheeley, ScD, senior scientific officer in the National Institute of General Medical Sciences (NIGMS).

"It is an important step in the process of making mass spectrometry data accessible and truly useful for clinicians," he says.

The image fusion project was led by Raf Van de Plas, PhD, a research assistant professor of biochemistry who also has a faculty position at Delft University of Technology in the Netherlands.

Using a mathematical approach called regression analysis, the researchers mapped each pixel of mass spectrometry data onto the corresponding spot on the microscopy image to produce a new, "predicted" image.

It's similar in concept to the line drawn between experimentally determined points in a standard curve, Caprioli says. There are no "real" points between those that were actually measured, yet the line is predicted by the previous experiments.

In the same way, "we're predicting what the data should look like," he says.

[Source: Vanderbilt University]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
Treating Drug-Resistant Acute Lymphoblastic Leukemia
New therapeutics may have helped improve survival rates for acute lymphoblastic leukemia patients but some patients still remain unresponsive to existing t...
OCT 14, 2019
Microbiology
OCT 14, 2019
A Canine Cancer That Began to Spread From One Dog About 6,000 Years Ago
Dogs can get different kinds of cancers, including one that is transmitted by live cancer cells, which spread through sexual contact....
OCT 14, 2019
Cancer
OCT 14, 2019
Not the fried food!
Stop! Put down those fries! Although we know that fried foods aren’t good for our health (though they sure do taste good!), new research from UMass A...
OCT 14, 2019
Cancer
OCT 14, 2019
The role of sleeper cells in metastasis
New research published in the journal Nature Communications aims to explain why some breast cancers recur following cancer treatment. According to col...
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
Evolutionary-Busting Cancer Drug
Researchers at the Institute of Cancer Research in London have discovered that a new type of drug that blocks treatment in cancers. The drug works by inhib...
OCT 14, 2019
Cancer
OCT 14, 2019
Blood test to detect brain cancer
Research published recently in the journal Nature Communications, a new study details the potential of a blood test that is capable of identifying brain ca...
Loading Comments...